Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report
Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multiple lung nodules on chest radiography was referred...
Gespeichert in:
Veröffentlicht in: | Case Reports in Oncology 2019-09, Vol.12 (3), p.928-934 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 934 |
---|---|
container_issue | 3 |
container_start_page | 928 |
container_title | Case Reports in Oncology |
container_volume | 12 |
creator | Uematsu, Mao Kanemasa, Yusuke Nakamura, Shohei Funasaka, Chikako Kageyama, Akihiko Shimoyama, Tatsu Omuro, Yasushi |
description | Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multiple lung nodules on chest radiography was referred to our hospital. Computed tomography revealed bilateral lung nodules and a large pelvic mass, and brain magnetic resonance imaging (MRI) demonstrated multiple brain lesions. He developed progressive headache and nausea and underwent two craniotomies because of rapid tumor growth and intratumoral hemorrhage. Metastasis of choriocarcinoma was strongly suspected because of histological findings and detection of urine human chorionic gonadotropin (hCG). He immediately received chemotherapy with bleomycin, etoposide, and cisplatin (BEP). Although the pelvic mass and pulmonary lesions reduced in size and the β-hCG level decreased after one cycle of BEP, brain MRI displayed an increase in the size and number of brain metastases. He underwent whole-brain radiotherapy (WBRT) concurrently with 2 cycles of BEP, leading to successful reduction of brain metastases. After 4 cycles of BEP, the β-hCG level was still higher than the normal range, and the pelvic and pulmonary lesions remained. He continued chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) and etoposide, ifosfamide, and cisplatin (VIP). The β-hCG level normalized, and the residual pelvic mass was resected, revealing no viable cancer cells. Multimodal treatment, including two craniotomies and chemotherapy concurrent with WBRT, can achieve good control of lesions of the brain and other sites. |
doi_str_mv | 10.1159/000504933 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmed_primary_32110211</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A630993795</galeid><doaj_id>oai_doaj_org_article_86f8cb3e5b6743588f4195fdb61abfac</doaj_id><sourcerecordid>A630993795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c552t-3aae058d418f6268290de771d88a0a3627e1b53bb1c9288dccfa4eb0782fc20e3</originalsourceid><addsrcrecordid>eNptkstv1DAQhyMEoqVw4I6QJU4ctvgROw4HpCUqUGmrSlU5WxM_st4mceokPP573GZZWgnZlkczv_k8Y02WvSb4lBBefsAYc5yXjD3JjokQdCV4wZ8-sI-yF-O4w1iUXPDn2RGjhOB0jrObi7mdfBcMtOg6Wpg6208oOHT2a4rQhB7uItU2RB80RO370AH66actus8cWos-R_A9gt6gzdw36MJOMKZtx49ojapkoCs7hDi9zJ45aEf7an-fZN-_nF1X31aby6_n1Xqz0pzTacUALObS5EQ6QYWkJTa2KIiREjAwQQtLas7qmuiSSmm0dpDbGheSOk2xZSfZ-cI1AXZqiL6D-FsF8OreEWKjIE5et1ZJ4aSumeW1KHLGpXQ5KbkztSBQO9CJ9WlhDXPdWaPT70RoH0EfR3q_VU34oQrMBJd5ArzbA2K4ne04qV2YY5_6VzQnOc9zSWVSnS6qBlJVvnchwXRaxnZeh946n_xrwXBZsqLkKeH9kqBjGMdo3aEkgtXdUKjDUCTt24c9HJR_p-BfjTcQGxsPgurqckGowbikevNf1f6VP9REx1E</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414544828</pqid></control><display><type>article</type><title>Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Karger Open Access</source><source>PubMed Central</source><creator>Uematsu, Mao ; Kanemasa, Yusuke ; Nakamura, Shohei ; Funasaka, Chikako ; Kageyama, Akihiko ; Shimoyama, Tatsu ; Omuro, Yasushi</creator><creatorcontrib>Uematsu, Mao ; Kanemasa, Yusuke ; Nakamura, Shohei ; Funasaka, Chikako ; Kageyama, Akihiko ; Shimoyama, Tatsu ; Omuro, Yasushi</creatorcontrib><description>Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multiple lung nodules on chest radiography was referred to our hospital. Computed tomography revealed bilateral lung nodules and a large pelvic mass, and brain magnetic resonance imaging (MRI) demonstrated multiple brain lesions. He developed progressive headache and nausea and underwent two craniotomies because of rapid tumor growth and intratumoral hemorrhage. Metastasis of choriocarcinoma was strongly suspected because of histological findings and detection of urine human chorionic gonadotropin (hCG). He immediately received chemotherapy with bleomycin, etoposide, and cisplatin (BEP). Although the pelvic mass and pulmonary lesions reduced in size and the β-hCG level decreased after one cycle of BEP, brain MRI displayed an increase in the size and number of brain metastases. He underwent whole-brain radiotherapy (WBRT) concurrently with 2 cycles of BEP, leading to successful reduction of brain metastases. After 4 cycles of BEP, the β-hCG level was still higher than the normal range, and the pelvic and pulmonary lesions remained. He continued chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) and etoposide, ifosfamide, and cisplatin (VIP). The β-hCG level normalized, and the residual pelvic mass was resected, revealing no viable cancer cells. Multimodal treatment, including two craniotomies and chemotherapy concurrent with WBRT, can achieve good control of lesions of the brain and other sites.</description><identifier>ISSN: 1662-6575</identifier><identifier>EISSN: 1662-6575</identifier><identifier>DOI: 10.1159/000504933</identifier><identifier>PMID: 32110211</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Brain cancer ; brain metastases ; Brain research ; Cancer metastasis ; Cancer therapies ; Care and treatment ; Case Report ; Case reports ; Case studies ; chemoradiotherapy ; Chemotherapy ; Choriocarcinoma ; Complications and side effects ; Diagnosis ; Drug therapy ; germ cell tumor ; Hemorrhage ; Laboratories ; Lung cancer ; Magnetic resonance imaging ; Medical prognosis ; Metastasis ; multimodal treatment ; Neurotoxicity ; Patients ; Radiation therapy ; Surgery ; Testicular cancer ; Toxicity ; Tumors</subject><ispartof>Case Reports in Oncology, 2019-09, Vol.12 (3), p.928-934</ispartof><rights>2019 The Author(s) Published by S. Karger AG, Basel</rights><rights>Copyright © 2019 by S. Karger AG, Basel.</rights><rights>COPYRIGHT 2019 S. Karger AG</rights><rights>Copyright © 2019 by S. Karger AG, Basel 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c552t-3aae058d418f6268290de771d88a0a3627e1b53bb1c9288dccfa4eb0782fc20e3</citedby><cites>FETCH-LOGICAL-c552t-3aae058d418f6268290de771d88a0a3627e1b53bb1c9288dccfa4eb0782fc20e3</cites><orcidid>0000-0003-0585-4884</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036584/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036584/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,27635,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32110211$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uematsu, Mao</creatorcontrib><creatorcontrib>Kanemasa, Yusuke</creatorcontrib><creatorcontrib>Nakamura, Shohei</creatorcontrib><creatorcontrib>Funasaka, Chikako</creatorcontrib><creatorcontrib>Kageyama, Akihiko</creatorcontrib><creatorcontrib>Shimoyama, Tatsu</creatorcontrib><creatorcontrib>Omuro, Yasushi</creatorcontrib><title>Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report</title><title>Case Reports in Oncology</title><addtitle>Case Rep Oncol</addtitle><description>Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multiple lung nodules on chest radiography was referred to our hospital. Computed tomography revealed bilateral lung nodules and a large pelvic mass, and brain magnetic resonance imaging (MRI) demonstrated multiple brain lesions. He developed progressive headache and nausea and underwent two craniotomies because of rapid tumor growth and intratumoral hemorrhage. Metastasis of choriocarcinoma was strongly suspected because of histological findings and detection of urine human chorionic gonadotropin (hCG). He immediately received chemotherapy with bleomycin, etoposide, and cisplatin (BEP). Although the pelvic mass and pulmonary lesions reduced in size and the β-hCG level decreased after one cycle of BEP, brain MRI displayed an increase in the size and number of brain metastases. He underwent whole-brain radiotherapy (WBRT) concurrently with 2 cycles of BEP, leading to successful reduction of brain metastases. After 4 cycles of BEP, the β-hCG level was still higher than the normal range, and the pelvic and pulmonary lesions remained. He continued chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) and etoposide, ifosfamide, and cisplatin (VIP). The β-hCG level normalized, and the residual pelvic mass was resected, revealing no viable cancer cells. Multimodal treatment, including two craniotomies and chemotherapy concurrent with WBRT, can achieve good control of lesions of the brain and other sites.</description><subject>Brain cancer</subject><subject>brain metastases</subject><subject>Brain research</subject><subject>Cancer metastasis</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Case studies</subject><subject>chemoradiotherapy</subject><subject>Chemotherapy</subject><subject>Choriocarcinoma</subject><subject>Complications and side effects</subject><subject>Diagnosis</subject><subject>Drug therapy</subject><subject>germ cell tumor</subject><subject>Hemorrhage</subject><subject>Laboratories</subject><subject>Lung cancer</subject><subject>Magnetic resonance imaging</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>multimodal treatment</subject><subject>Neurotoxicity</subject><subject>Patients</subject><subject>Radiation therapy</subject><subject>Surgery</subject><subject>Testicular cancer</subject><subject>Toxicity</subject><subject>Tumors</subject><issn>1662-6575</issn><issn>1662-6575</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DOA</sourceid><recordid>eNptkstv1DAQhyMEoqVw4I6QJU4ctvgROw4HpCUqUGmrSlU5WxM_st4mceokPP573GZZWgnZlkczv_k8Y02WvSb4lBBefsAYc5yXjD3JjokQdCV4wZ8-sI-yF-O4w1iUXPDn2RGjhOB0jrObi7mdfBcMtOg6Wpg6208oOHT2a4rQhB7uItU2RB80RO370AH66actus8cWos-R_A9gt6gzdw36MJOMKZtx49ojapkoCs7hDi9zJ45aEf7an-fZN-_nF1X31aby6_n1Xqz0pzTacUALObS5EQ6QYWkJTa2KIiREjAwQQtLas7qmuiSSmm0dpDbGheSOk2xZSfZ-cI1AXZqiL6D-FsF8OreEWKjIE5et1ZJ4aSumeW1KHLGpXQ5KbkztSBQO9CJ9WlhDXPdWaPT70RoH0EfR3q_VU34oQrMBJd5ArzbA2K4ne04qV2YY5_6VzQnOc9zSWVSnS6qBlJVvnchwXRaxnZeh946n_xrwXBZsqLkKeH9kqBjGMdo3aEkgtXdUKjDUCTt24c9HJR_p-BfjTcQGxsPgurqckGowbikevNf1f6VP9REx1E</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Uematsu, Mao</creator><creator>Kanemasa, Yusuke</creator><creator>Nakamura, Shohei</creator><creator>Funasaka, Chikako</creator><creator>Kageyama, Akihiko</creator><creator>Shimoyama, Tatsu</creator><creator>Omuro, Yasushi</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0585-4884</orcidid></search><sort><creationdate>20190901</creationdate><title>Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report</title><author>Uematsu, Mao ; Kanemasa, Yusuke ; Nakamura, Shohei ; Funasaka, Chikako ; Kageyama, Akihiko ; Shimoyama, Tatsu ; Omuro, Yasushi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c552t-3aae058d418f6268290de771d88a0a3627e1b53bb1c9288dccfa4eb0782fc20e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Brain cancer</topic><topic>brain metastases</topic><topic>Brain research</topic><topic>Cancer metastasis</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Case studies</topic><topic>chemoradiotherapy</topic><topic>Chemotherapy</topic><topic>Choriocarcinoma</topic><topic>Complications and side effects</topic><topic>Diagnosis</topic><topic>Drug therapy</topic><topic>germ cell tumor</topic><topic>Hemorrhage</topic><topic>Laboratories</topic><topic>Lung cancer</topic><topic>Magnetic resonance imaging</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>multimodal treatment</topic><topic>Neurotoxicity</topic><topic>Patients</topic><topic>Radiation therapy</topic><topic>Surgery</topic><topic>Testicular cancer</topic><topic>Toxicity</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uematsu, Mao</creatorcontrib><creatorcontrib>Kanemasa, Yusuke</creatorcontrib><creatorcontrib>Nakamura, Shohei</creatorcontrib><creatorcontrib>Funasaka, Chikako</creatorcontrib><creatorcontrib>Kageyama, Akihiko</creatorcontrib><creatorcontrib>Shimoyama, Tatsu</creatorcontrib><creatorcontrib>Omuro, Yasushi</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Case Reports in Oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uematsu, Mao</au><au>Kanemasa, Yusuke</au><au>Nakamura, Shohei</au><au>Funasaka, Chikako</au><au>Kageyama, Akihiko</au><au>Shimoyama, Tatsu</au><au>Omuro, Yasushi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report</atitle><jtitle>Case Reports in Oncology</jtitle><addtitle>Case Rep Oncol</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>12</volume><issue>3</issue><spage>928</spage><epage>934</epage><pages>928-934</pages><issn>1662-6575</issn><eissn>1662-6575</eissn><abstract>Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multiple lung nodules on chest radiography was referred to our hospital. Computed tomography revealed bilateral lung nodules and a large pelvic mass, and brain magnetic resonance imaging (MRI) demonstrated multiple brain lesions. He developed progressive headache and nausea and underwent two craniotomies because of rapid tumor growth and intratumoral hemorrhage. Metastasis of choriocarcinoma was strongly suspected because of histological findings and detection of urine human chorionic gonadotropin (hCG). He immediately received chemotherapy with bleomycin, etoposide, and cisplatin (BEP). Although the pelvic mass and pulmonary lesions reduced in size and the β-hCG level decreased after one cycle of BEP, brain MRI displayed an increase in the size and number of brain metastases. He underwent whole-brain radiotherapy (WBRT) concurrently with 2 cycles of BEP, leading to successful reduction of brain metastases. After 4 cycles of BEP, the β-hCG level was still higher than the normal range, and the pelvic and pulmonary lesions remained. He continued chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) and etoposide, ifosfamide, and cisplatin (VIP). The β-hCG level normalized, and the residual pelvic mass was resected, revealing no viable cancer cells. Multimodal treatment, including two craniotomies and chemotherapy concurrent with WBRT, can achieve good control of lesions of the brain and other sites.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>32110211</pmid><doi>10.1159/000504933</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-0585-4884</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1662-6575 |
ispartof | Case Reports in Oncology, 2019-09, Vol.12 (3), p.928-934 |
issn | 1662-6575 1662-6575 |
language | eng |
recordid | cdi_pubmed_primary_32110211 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Karger Open Access; PubMed Central |
subjects | Brain cancer brain metastases Brain research Cancer metastasis Cancer therapies Care and treatment Case Report Case reports Case studies chemoradiotherapy Chemotherapy Choriocarcinoma Complications and side effects Diagnosis Drug therapy germ cell tumor Hemorrhage Laboratories Lung cancer Magnetic resonance imaging Medical prognosis Metastasis multimodal treatment Neurotoxicity Patients Radiation therapy Surgery Testicular cancer Toxicity Tumors |
title | Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T10%3A00%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multimodal%20Treatment%20of%20Extragonadal%20Choriocarcinoma%20with%20Multiple%20Brain%20and%20Lung%20Metastases:%20A%20Case%20Report&rft.jtitle=Case%20Reports%20in%20Oncology&rft.au=Uematsu,%20Mao&rft.date=2019-09-01&rft.volume=12&rft.issue=3&rft.spage=928&rft.epage=934&rft.pages=928-934&rft.issn=1662-6575&rft.eissn=1662-6575&rft_id=info:doi/10.1159/000504933&rft_dat=%3Cgale_pubme%3EA630993795%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2414544828&rft_id=info:pmid/32110211&rft_galeid=A630993795&rft_doaj_id=oai_doaj_org_article_86f8cb3e5b6743588f4195fdb61abfac&rfr_iscdi=true |